Michael Barton
Michael Barton
Professor of Radiation Oncology, Ingham Institute, UNSW
Verified email at - Homepage
Cited by
Cited by
The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence‐based clinical guidelines
G Delaney, S Jacob, C Featherstone, M Barton
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
Expanding global access to radiotherapy
R Atun, DA Jaffray, MB Barton, F Bray, M Baumann, B Vikram, TP Hanna, ...
The lancet oncology 16 (10), 1153-1186, 2015
The effect of treatment duration in the local control of cervix cancer
A Fyles, TJ Keane, M Barton, J Simm
Radiotherapy and Oncology 25 (4), 273-279, 1992
Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012
MB Barton, S Jacob, J Shafiq, K Wong, SR Thompson, TP Hanna, ...
Radiotherapy and oncology 112 (1), 140-144, 2014
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
G Morgan, R Ward, M Barton
Clinical oncology 16 (8), 549-560, 2004
Role of radiotherapy in cancer control in low-income and middle-income countries
MB Barton, M Frommer, J Shafiq
The lancet oncology 7 (7), 584-595, 2006
The Australian magnetic resonance imaging–linac program
PJ Keall, M Barton, S Crozier
Seminars in radiation oncology 24 (3), 203-206, 2014
The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer
MB Barton, TJ Keane, T Gadalla, E Maki
Radiotherapy and Oncology 23 (3), 137-143, 1992
Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma
P O’Brien, D Roos, G Pratt, K Liew, M Barton, M Poulsen, I Olver, G Trotter
Journal of Clinical Oncology 18 (3), 519-519, 2000
The potential for an enhanced role for MRI in radiation-therapy treatment planning
P Metcalfe, GP Liney, L Holloway, A Walker, M Barton, GP Delaney, ...
Technology in cancer research & treatment 12 (5), 429-446, 2013
An international review of patient safety measures in radiotherapy practice
J Shafiq, M Barton, D Noble, C Lemer, LJ Donaldson
Radiotherapy and Oncology 92 (1), 15-21, 2009
The effect of waiting for radiotherapy for grade III/IV gliomas
V Do, V Gebski, MB Barton
Radiotherapy and Oncology 57 (2), 131-136, 2000
The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis
JM Borras, Y Lievens, P Dunscombe, M Coffey, J Malicki, J Corral, ...
Radiotherapy and Oncology 116 (1), 38-44, 2015
Management of skin toxicity during radiation therapy: a review of the evidence
S Kumar, E Juresic, M Barton, J Shafiq
Journal of medical imaging and radiation oncology 54 (3), 264-279, 2010
A model for decision making for the use of radiotherapy in lung cancer
G Delaney, M Barton, S Jacob, B Jalaludin
The lancet oncology 4 (2), 120-128, 2003
Radiotherapy risk profile: technical manual
World Health Organization
Geneva, Switzerland: World Health Organization, 2008
Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group
A Wirth, K Yuen, M Barton, D Roos, K Gogna, G Pratt, C MacLeod, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
JM Borras, Y Lievens, M Barton, J Corral, J Ferlay, F Bray, C Grau
Radiotherapy and Oncology 119 (1), 5-11, 2016
Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
M Barton
International journal of radiation oncology, biology, physics 31 (2), 371-378, 1995
Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
MB Barton, G Morgan, R Smee, KW Tiver, C Hamilton, V Gebski
Radiotherapy and oncology 44 (2), 137-141, 1997
The system can't perform the operation now. Try again later.
Articles 1–20